🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

US physical therapy COO sells shares worth over $181k

Published 14/05/2024, 23:20
USPH
-

Graham D. Reeve, the Chief Operating Officer (COO) of U.S. Physical Therapy Inc. (NYSE:USPH), has recently sold a portion of his shares in the company. On May 10, 2024, Reeve sold 1,724 shares at a weighted average price of $105.46, totaling over $181,813.

The shares were sold in multiple transactions with prices ranging from $105.44 to $105.50. Reeve's remaining holdings in the company after this sale amount to 6,970 shares held indirectly through the Reeve Trust, as per the latest filing with the Securities and Exchange Commission.

Additionally, Reeve holds 16,468 shares directly, which were granted as restricted stock under the company's Amended and Restated 2003 Stock Incentive Plan. These shares are subject to restrictions that lapse on various dates stretching from July 1, 2024, to January 2028, contingent upon Reeve's continued directorship at the company.

Investors and followers of U.S. Physical Therapy Inc. often monitor the trading activities of insiders like Reeve for insights into the company's performance and management's perspective on the stock's valuation. Insider sales and purchases can provide valuable context to the market's understanding of a stock's potential.

U.S. Physical Therapy Inc., headquartered in Houston, Texas, operates clinics across the United States that offer physical and occupational therapy services. The company's stock is traded under the ticker symbol USPH on the New York Stock Exchange.

InvestingPro Insights

As investors evaluate the recent insider trading activity of U.S. Physical Therapy Inc.'s COO, Graham D. Reeve, it's crucial to consider the company's financial health and market performance. According to InvestingPro data, USPH has a market capitalization of approximately $1.6 billion and a Price to Earnings (P/E) ratio of 87.92, which has adjusted to 65.32 over the last twelve months as of Q1 2024. This high P/E ratio suggests that investors are paying a premium for the company's earnings, which is often the case for companies expected to grow earnings or that have high-quality earnings.

With a revenue growth of 7.35% over the last twelve months as of Q1 2024, the company demonstrates a steady increase in its ability to generate income. The modest revenue growth rate of 4.8% in Q1 2024, compared to the previous quarter, indicates a consistent performance that may reassure investors looking for stable returns.

InvestingPro Tips highlight that U.S. Physical Therapy Inc. has raised its dividend for three consecutive years and has maintained dividend payments for 14 consecutive years, signaling a commitment to returning value to shareholders. Additionally, the company's net income is expected to grow this year, providing a positive outlook for potential investors. With three analysts having revised their earnings upwards for the upcoming period, there appears to be a consensus on the company's promising financial trajectory.

For those interested in further insights and tips, there are 11 additional InvestingPro Tips available for USPH at InvestingPro. And remember, you can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, unlocking even more valuable investment information.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.